Comparing end tidal sevoflurane in cirrhotic and non cirrhotic patients undergoing major hepatic resection using bispectral index

none0 个研究点目标入组 20 人开始时间: 2017年9月29日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•- patient who was scheduled for major hepatic resection(definition is anatomic hepatic resection more than 2 segments such as right hepatectomy, left hepatectomy , extended right hepatectomy , left lobectomy or extended left hepatectomy) with specialty hepatobiliary surgeon under combined general-epidural anesthesia at King Chulalongkorn Memorial Hostipal
•- age 20-65 years
•- American Society of Anesthesiology Physical Status (ASA) I-III
•ASA I : A normal healthy patient (Examples include Healthy, non-smoking, no or minimal alcohol use)
•ASA II : A patient with mild systemic diseaseMild diseases only without substantive functional limitations (Examples include current smoker, social alcohol drinker, pregnancy, obesity (30 < BMI < 40), well-controlled DM/HTN, mild lung disease)
•ASA III : A patient with severe systemic disease (Substantive functional limitations; One or more moderate to severe diseases. Examples include (but not limited to): poorly controlled DM or HTN, COPD, morbid obesity (BMI â‰¥40), active hepatitis, alcohol dependence or abuse, implanted pacemaker, moderate reduction of ejection fraction, ESRD undergoing regularly scheduled dialysis, premature infant PCA < 60 weeks, history (>3 months) of MI, CVA, TIA, or CAD/stents.)

•- refuse to participate this study
•- allergy to any drug in this study
•- serious diseases other than liver diseases, such as cardiovascular, respiratory or
•endocrine system conditions
•- contraindication for epidural catheter
•- taking chronic sedatives drug and opioid
•- alcoholics or drug abuse
•- psychaitic problems
•- a body mass index (BMI) â‰¥30 kg/m 2
•- history of malignant hyperthermia

发起方

none